In  the margins of ‘Lisbon Addictions 2022’, EU4Monitoring Drugs (EU4MD) and EMCDDA IPA7 projects, both ending in 2022,  joined forces and organised a closing conference: ‘Drugs beyond EU borders: emerging trends and preparedness’.

The conference focused on cross-border drug-related health and security threats in the Western Balkans and on drug markets and emerging drug-related challenges in the ENP region. It was attended by over 80 participants coming from 18 partners, EU institutions and other bodies.

The event was also the occasion to launch 3 new reports (attached):

-           Overview of drug markets in the European Neighbourhood Policy-South countries (funded by EU4MD)

-           Overview of drug markets in the European Neighbourhood Policy-East countries (funded by EU4MD)

-           Drug-related health and security threats in the Western Balkans (funded by EMCDDA IPA7)

The reports present an analysis of the drug markets in the European Neighbourhood and Western Balkans. Focused on providing insights into drug production, trafficking, sale, use and harms, the reports contain data and information from a review of publicly available information and selected studies conducted between 2019 and 2022. They conclude with an outlook on key areas for policy and practice to address emerging drug market challenges.